Unicycive Therapeutics Inc. (UNCY)
Market Closed
17 Jul, 20:00
NASDAQ (CM) NASDAQ (CM) Primary $
5. 38
+0.33
+6.5347%
$
112.19M Market Cap
- P/E Ratio
- Div Yield
1.35M Volume
-0.49 Eps
$ 5.05
Previous Close 
Want to track UNCY and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Unicycive Therapeutics Inc. Analysts
| Name | Quantity | Cost | Value | Profit ($) | Gain (%) |
|---|---|---|---|---|---|
 Ed Arce WestPark Capital | -45,754.6 | $202,692.9 | $229,688.11 | -$26,995.21 | -13.32% |
 Vamil Divan Guggenheim | -60,432.61 | $404,144.09 | $325,127.43 | $79,016.66 | 19.55% |
 Mayank Mamtani B. Riley Securities | -104,070.89 | $749,310.42 | $522,435.87 | $226,874.55 | 30.28% |
| RL Robert LeBoyer Noble Capital Markets | 157,680.9 | $832,555.14 | $791,558.11 | -$40,997.03 | -4.92% |
